Risk of serious asthma exacerbations associated with long-acting beta agonists among patients with asthma: A retrospective cohort study
Authors:
- Jeff J. GuoJGJeff J. Guo
- Katherine TsaiKTKatherine Tsai
- Christina M.L. KeltonCKChristina M.L. Kelton
- Boyang BianBBBoyang Bian
- Patricia R. WiglePWPatricia R. Wigle
- 1 March 2011
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 106 (3) , 214-222.e2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trialThe Lancet, 2009
- The Salmeterol Multicenter Asthma Research Trial: A Comparison of Usual Pharmacotherapy for Asthma or Usual Pharmacotherapy Plus SalmeterolPediatrics, 2007
- Molecular mechanisms of β2-adrenergic receptor function, response, and regulationJournal of Allergy and Clinical Immunology, 2006
- Long-Acting ??2-Agonists in AsthmaDrug Safety, 2006
- Impact of school-based health centers on children with asthmaJournal of Adolescent Health, 2005
- Effect of long‐acting β2 agonists on exacerbation rates of asthma in childrenPediatric Pulmonology, 2003
- Risk factors for death from asthmaAnnals of Allergy, Asthma & Immunology, 1999
- Undertreatment in a nonselected population of adult patients with asthmaJournal of Allergy and Clinical Immunology, 1996
- Clinicians and patients with hypertension: Unsettled issues about complianceAmerican Heart Journal, 1995
- The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hoursJournal of Allergy and Clinical Immunology, 1992